U.S. Department of Commerce Office of Security

Luis Hernandez, Strategic New Hire, Unique Forensic Technology Products and Services

Retrieved on: 
Thursday, August 11, 2022 - 4:25pm

PUNTA GORDA, Fla., Aug. 11, 2022 /PRNewswire-PRWeb/ -- Cambridge Federal, Cambridge Forensics (dba) is pleased to announce the appointment of Mr. Luis Hernandez as the Managing Partner and Director of the Supply Chain Division for Cambridge Forensics. Cambridge Forensics has recently launched it's new forensic tracing and coding line from the SmartWater Group for Supply Chains to it's list of products; Mr. Hernandez will be the resident expert on solutions for all things Supply Chain – welcome to the team!

Key Points: 
  • Cambridge Federal is committed to fostering economic development and career opportunities for the surrounding community.
  • Luis Hernandez has been a Defense Criminal Investigative Service (DCIS) Special Agent, and Program Manager Counterproliferation investigations.
  • Cambridge Forensics is headquartered in Punta Gorda, Florida, and has created a research and development lab investigating unique solutions leveraging the SmartWater Group unique forensic coded products and services for Supply Chain, Law Enforcement, and Medical Contagious Disease Training (CDT) initiatives.
  • Luis Hernandez (Supply Chain Director) LinkedIn: https://www.linkedin.com/in/luis-hernandez-39526963
    Kelli Clark (Office Manager) LinkedIn: linkedin.com/in/kelli-clark-41091697

Worldwide Cleanroom Gloves Industry to 2030 - Key Players are Adopting Various Inorganic Strategies Such as Acquisitions Which are Expected to Drive Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 11, 2022 - 12:04pm

Cleanroom gloves are developed to prevent particulate contamination, meet stringent industry standards and requirements.

Key Points: 
  • Cleanroom gloves are developed to prevent particulate contamination, meet stringent industry standards and requirements.
  • Cleanroom gloves are washed in pure deionized water to remove the particulates and ions and are chlorinated from both sides i.e.
  • The key players in the market are adopting various inorganic strategies such as acquisitions, which is expected to drive the market growth over the forecast period.
  • Hence, the company is undertaking various strategies such as acquisition to drive the global cleanroom gloves market growth.

iProov Achieves eIDAS eID Level of Assurance High for Genuine Presence Assurance

Retrieved on: 
Thursday, August 11, 2022 - 8:00am

iProov , the world leader in face biometric authentication technology, announced today that it is certified for biometric face verification of a natural person with its Genuine Presence Assurance technology to Level of Assurance High (LoA High) in accordance with the eIDAS regulation.

Key Points: 
  • iProov , the world leader in face biometric authentication technology, announced today that it is certified for biometric face verification of a natural person with its Genuine Presence Assurance technology to Level of Assurance High (LoA High) in accordance with the eIDAS regulation.
  • The eID Assurance LoA High certification ensures that European Union (EU) governments and organizations using iProovs Genuine Presence Assurance are capable of electronically verifying users across Europe with the highest level of certainty and security.
  • iProovs Genuine Presence Assurance is compliant with the relevant requirements for Biometric face verification of a natural person, following the regulation Reg.
  • 910/2014 (eIDAS) Article 8 (2) according to eIDAS eID Level of Assurance high.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Inotiv, Inc. - NOTV

Retrieved on: 
Wednesday, August 10, 2022 - 6:58pm

NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Inotiv, Inc. (Inotiv or the Company) (NASDAQ: NOTV).

Key Points: 
  • NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Inotiv, Inc. (Inotiv or the Company) (NASDAQ: NOTV).
  • Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext.
  • The investigation concerns whether Inotiv and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Inotiv, Inc. (NOTV)

Retrieved on: 
Wednesday, August 10, 2022 - 4:00pm

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.
  • On this news, Inotivs stock fell $5.19, or 28.3%, to close at $13.14 per share on May 23, 2022, thereby injuring investors.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

Monkeypox Update: FDA Authorizes Emergency Use of JYNNEOS Vaccine to Increase Vaccine Supply

Retrieved on: 
Tuesday, August 9, 2022 - 8:53pm

"In recent weeks the monkeypox virus has continued to spread at a rate that has made it clear our current vaccine supply will not meet the current demand," said FDA Commissioner Robert M. Califf, M.D.

Key Points: 
  • "In recent weeks the monkeypox virus has continued to spread at a rate that has made it clear our current vaccine supply will not meet the current demand," said FDA Commissioner Robert M. Califf, M.D.
  • "The FDA quickly explored other scientifically appropriate options to facilitate accessto the vaccine for all impacted individuals.
  • By increasing the number of available doses, more individuals who want to be vaccinated against monkeypox will now have the opportunity to do so."
  • Individuals who received the vaccine intradermally received a lower volume (one fifth) than individuals who received the vaccine subcutaneously.

NIIMBL Announces $15.8M to Fund 14 New Biopharmaceutical Manufacturing Projects

Retrieved on: 
Tuesday, August 9, 2022 - 7:30pm

These projects were selected to best align with key areas of focus identified by NIIMBL and which best align to address industry needs.

Key Points: 
  • These projects were selected to best align with key areas of focus identified by NIIMBL and which best align to address industry needs.
  • Project Call 5.2 also included several workforce development projects that provide a variety of opportunities to those interested in entering or developing skills within the biopharmaceutical manufacturing industry.
  • The NIIMBL community is comprised of more than 200 members from academia, industry, government, and non-profit organizations all sharing a common goal to advance biopharmaceutical manufacturing.
  • The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is a public-private partnership whose mission is to accelerate biopharmaceutical innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical manufacturing workforce, fundamentally advancing U.S. competitiveness in this industry.

Congress Adds "Community" as the 7th Category of the Malcolm Baldrige National Quality Awards

Retrieved on: 
Tuesday, August 9, 2022 - 4:21pm

WASHINGTON, Aug. 9, 2022 /PRNewswire/ -- Earlier today, President Biden signed into law the CHIPS and Science Act of 2022, which also authorized "Community" becoming the seventh category of the Malcolm Baldrige National Quality Awards.

Key Points: 
  • WASHINGTON, Aug. 9, 2022 /PRNewswire/ -- Earlier today, President Biden signed into law the CHIPS and Science Act of 2022, which also authorized "Community" becoming the seventh category of the Malcolm Baldrige National Quality Awards.
  • Tommy Gonzalez, City Manager of El Paso, Texas, formerly led the City of Irving, Texas to win the Malcolm Baldrige National Quality Award using the Nonprofit Criteria in 2012.
  • We have worked relentlessly to promote "Community" as the seventh category of the Baldrige Awards and have seen true, bipartisan support in Congress for this initiative.
  • The Baldrige Program located at NIST within the U.S. Department of Commerce, is a separate entity and is solely responsible for managing and administering the Malcolm Baldrige National Quality Award.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of Investors

Retrieved on: 
Monday, August 8, 2022 - 5:00pm

Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT ) investors concerning the Companys possible violations of the federal securities laws.

Key Points: 
  • Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT ) investors concerning the Companys possible violations of the federal securities laws.
  • On this news, Fulgents stock fell as much as 8% during intraday trading on August 5, 2022, thereby injuring investors.
  • Whistleblower Notice: Persons with non-public information regarding Fulgent should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program.
  • Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.

Lawsuit Filed to Stop Wastage of EB-5 Investor Visas

Retrieved on: 
Saturday, August 6, 2022 - 4:02am

This lawsuit seeks to compel the State Department to follow the plain language of its own regulations...

Key Points: 
  • This lawsuit seeks to compel the State Department to follow the plain language of its own regulations...
  • Approximately 18,000 EB-5 visas were wasted last fiscal year and cannot be used anymore without Congressional action.
  • In fiscal year 2022, ending September 30, 2022, over 11,000 immigrant visas should be available to China-mainland EB5 investors, and it is almost certain most of these will be wasted.
  • Without judicial intervention, they will be waiting many more years for a green card while the government wastes thousands of visas.